BCYC
Bicycle Therapeutics plc
Company Overview
| Mkt Cap | $569.70M | Price | $8.07 |
| Volume | 309.26K | Change | -7.88% |
| P/E Ratio | -3.4 | Open | $8.23 |
| Revenue | $35.3M | Prev Close | $8.76 |
| Net Income | $-169.0M | 52W Range | $6.10 - $25.39 |
| Div Yield | N/A | Target | $24.90 |
| Overall | 56 | Value | 60 |
| Quality | 44 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyBicycle Therapeutics plc (BCYC) is a leading Healthcare company in the Biotechnology industry, currently trading at $8.07 with a market capitalization of $569.70 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows BCYC with a volume of 309K shares. The stock opened down 6.05% from yesterday's close of $8.76. Current analyst estimates project earnings of $-4.22 per share for this year, with next year targeting $-4.
BCYC demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ORTH-CA, OTIC, OTLC, OTLK.
Key investment considerations for BCYC include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 208.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:22 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCYC | $8.07 | -7.9% | 309.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicycle Therapeutics plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW